RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
This phase II trial studies how well RO4929097 works in treating patients with metastatic colorectal cancer. RO4929097 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Epistemonikos ID: 549c8d318e8985cc70b978d07703b245e5ef2525
First added on: May 05, 2024